SlideShare a Scribd company logo
DISCLOSURE
Advisory Board        Novartis
Research            Aztra Zeneca
                   Sanofi Aventis
                  Schering Plough
                     Asofarma
                        Pfizer
                   Merck Serono
                 Merck Sharp Dohme
                        Bayer
                       Abbott
                       Servier
                       Roche
                     Menarini
                       Takeda
                       Ferrer
Globalization / Urbanization and the Epidemiologic Transition

Economic Growth, Income, Employment
     and Cardiovascular Disease




                     Dr. Fernando Stuardo Wyss Quintana Md, Phd, GCSM, ESHM, ESCM
                       Vice-president of Interamerican Society of Cardiology
                                            Guatemala City, Guatemala, C.A.
                                                            fernandowyss@gmail.com
Our final Conclusion be that from the point of view of
               Cardiovascular Disease
          powerfuls, arrogants and impotents
The National Survey of Living Conditions ENCOVI 2006


       Vital Basic Basket and Minimum Wage



                VITAL BASIC BASKET



                                      FOOD

                  AGRICULTURE WAGE                         NOT AGRICULTURE WAGE




               Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
The National Survey of Living Conditions ENCOVI 2006



       Vital Basic Basket and Minimum Wage
In accordance with Government Agreement No. 388-2010 published in the Journal
 of Central America, December 30, 2010, establishes the new minimum wage that
                         governed from January 1, 2011.

- Agriculture / not Agriculture Q. 2,187.54 per month               $ 276.90

- Export and manufacture              Q. 2,058.27 per month         $ 260.24

- Cardiologist in GH                  Q. 4,000.00 per month         $ 506.32




                    Wyss; Source: Based on data: Guatemala 2011 government salary
The National Survey of Living Conditions ENCOVI 2006

    Guatemala: Poverty nationwide distribution of poverty by ethnic
  identity National Survey of Living Conditions 2006 ENCOVI absolute
                         and relative numbers
 80%          75
 70                                                                         64
 60
         51                                                       49
 50                                                 48
                                                                                     All Population
 40                36                          36
                                                           29                        Indigenous
 30                               27                                   25
                                                                                     Non-Indigenous
 20                          15
 10                                    8

  0
          All Poor        Extremely Poor            Poor          Not Poor

      N = 12,987,829
                   Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
The National Survey of Living Conditions ENCOVI 2006

              Guatemala: Poverty Incidence by Region




                                                                            All Poor´                 51%
                                                                            Extremely poor            15%
                                                                            Poor                      36%
                                                                            Not Poor                  49%




                       Wyss; Source: Based on data from the National Survey of Living Conditions ENCOVI 2006.
The National Survey of Living Conditions ENCOVI 2006

Incidence of Poverty in each Department
                                   Poor                   Not Poor




               Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
The National Survey of Living Conditions ENCOVI 2006

     Guatemala: Social Spending on Education, Health and Housing
          % Of GDP (Gross Domestic Product), 2001 -2007.

                  Education                     Health                   Housing




                                                                                       1.75
                                                                                       74 %




               Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
The National Survey of Living Conditions ENCOVI 2006


    Guatemala: Social Spending on Health % Of GDP
        (Gross Domestic Product), 2001 -2007.
                                   % GDP 2001 - 2007



                                                                                   Guatemala
                                                                                   El Salvador
                                                                                   Honduras
                                                                                   Nicaragua
                                                                                   Costa Rica
                                                                                   Panama




               Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
Cardiovascular Risk Assessment in
                Guatemala

• General population
• Bedroom City´s
• Chronically ill population
• High-income population
Data in Pediatric Populations


              OBESITY IN ELEMENTARY SCHOOL
              EDUCATION, UNIVERSITY OF SAN
                  CARLOS DE GUATEMALA


                             67%


               Dr. Luis Moya MD, PhD; Verbal Information
Cardiometabolic Risk Factors
                 Guatemalan Heart League
  7000



  5250



  3500



  1750



     0

              2001   2002   2003   2004      2005        2006         2007
                                                  Hypertension
N = 111,201
                                                  Diabetes Mellitus
                                                  Dyslipidemia

                                    Dr. Wyss, Data Base; Guatemalan Heart League
Cardiometabolic Risk Factors
               Guatemalan Heart League
       %              35 34
     35
     30
                 25
     25
      20
                                                                                       2001
      15
                                                                                       2007
      10
                                       8   8                                           2008
       5                           4                        6    6
          0                                             3

               Hypertension
                              Diabetes Mellitus
                                                     Dyslipidemia
N = 111,201
                                                  Dr. Wyss, Data Base; Guatemalan Heart League
Ciudad Dormitorio
                     Commuter Town Study
                       Sx. Metabólico Ciudad Villa Nueva
       The Villa Nueva Study, Cardiovascular CDC
         Porcentaje de Factores de Riesgo
                                          OPS, OMS
       0                        15                    30                45                 60




                                                                                     55%

                                                 29%

FRCV                                   23%

                                                               40%

                                                                                 54%
            Abnormal glucouse
           Gl ucemia anor mal        Hiper t ension
                                     Hypertension      Overweigth
                                                       Sobr epeso     Obesity
                                                                     Obesidad     Cint ur a Circunference
                                                                                  Abdominal


                                                                                OPS, OMS, Villa Nueva Study Paper
Prevalence de Síndrome Syndrome
         Prevalencia of Metabolic Metabólico
                Clínica de Hipertensión
    Hypertension Unit, St. Jhon of God General Hospital
          Hospital General San Juan de Dios
                                                                                                               1100
       100%

                                                                                               90%

                                                                                                               825
                             70%
                      65%


                                                 55%                                                       550
                                       48%                 45%




                                                                                24%
                                                                                                           275
                                                                        21%



                                                                                                           0

       Hypertension
       Hipertensión    HDL   TG    Colesterol   LDL     Glucosa > 100    DM2     Prediabetes    Obesidad
                                                                                                 Obesity

N = 1005

8 com ponentes aislados            Dr. Wyss, in print,Dr. Fernando Wyss, unidad and St. Jhon of God General Hospital
                                         Fuente: database Cardioclinik Research Unit de cardiología HGSJDD
Global Cardiovascular Risk Assessment in an apparently healthy population
    EVRICARDS
•    398 patients
•    Routine Cardiovascular Screening             Perfil PROFILE
                                                       LIPID
                                                             Lípidos
•    High income                                                                                                                      300

•    Lifestyle modification                                               58%
                                                                                                                                      225
                                                                    51%
•    Fitness cardiovascular activity    44%

•    Play Golf                                  32%           29%
                                                                                                                                      150


•    Balanced diet                                    19%
                                                                                                                                     75

•    They drink wine
                                                                 177 p   128 p   76 p        116 p         205 p        231 p        0
                                                                                        LIPIDOS
                                                                                                      Colesterol   HDL - M     HDL - F
                                                                                                      LDL > 130    LDL > 100   Trigliceridos
                 Clasificación PRESURE
                         BLOOD Presión Arterial

                             P. Sistólica        P. Diastólica
                                                                                                            Fernando Wyss; in press, 2 0 1 0
                         0
                                   22,5
                                            45
                                                             67,5
                                                                           90
            Normal
                             40%
                                                   38%
    Pre- hipertensión
                             40%
            Estadio 1
                                                    42%
                         10% 11%
             Estadio 2
                         10% 9%

                                                                                                  Fernando Wyss; in press, 2010
Economic Growth, Income, Employment
    and Cardiovascular Disease ??
  We have a social difference in the appearance of
             cardiovascular disease ?
Gross Domestic Product and Health Expenditure Associated With
Incidence, 30-Day Fatality, and Age at Stroke Onset, A Systematic
Review
Luciano A. Sposato, MD, MBA; Gustavo Saposnik, MD, MSc, FAHA

This study demonstrated an association between low GDP
of a country:

1. A 32% increase stroke risk

2. An increase in the rate of death at 30 days post-stroke by 43%

3. An excess of 43% in intracerebral hemorrhage

4. An increase of almost double the incidence of stroke in young
   individuals.

                                                               Stroke. 2012; 43 /doi: 10.1161/​STROKEAHA.111.632158
Gross Domestic Product and Health Expenditure Associated With
Incidence, 30-Day Fatality, and Age at Stroke Onset, A Systematic
Review
Luciano A. Sposato, MD, MBA; Gustavo Saposnik, MD, MSc, FAHA



  Also, a low total health expenditure was correlated with a
  proportional increase in the rate of death at 30 days and:

  1. A 26% increase stroke risk

  2. An increase of 45% death rate at 30 days post-stroke

  3. An excess of 32% in intracerebral hemorrhage

  4. A 36% increase in the incidence of stroke in young individuals.
                                                               Stroke. 2012; 43 /doi: 10.1161/​STROKEAHA.111.632158
Intervention Model
High Income and compare the Relative Risk Reduction of Low-Income
Cardiometabolic Risk Factors
      Differences Between High-Income and Low-Incomes Populations
                                          Obesity
100                RRR 4%   28                            RRR 11% 26
           29                                    29
90
80
70
           161              169                 151                   157
60
                                                                                                BMI
50
                                                                                                HEIGHT cm
40
                                                                                                WEIGTH kg
30
20         74               80                   65                    66
10
 0                                                                                             N = 1403
       POOR male      NOT POOR          POOR female            NOT POOR
                        male                                    female
                      Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
Cardiometabolic Risk Factors
   Differences Between High-Income and Low-Incomes Populations
                          Abdominal Circunference




                     96                                   90
NOT POOR

                                                                                           MALE
                                                        RRR 5%                             FEMALE



                     94                                   94
   POOR
                                                                                         N = 1403
           0    20           40             60            80            100

                Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
Cardiometabolic Risk Factors
 Differences Between High-Income and Low-Incomes Populations


        RRR         9%               27%                 18%                32%

 70 %                            65                 70
                                                             58
 60                     44              48                                   51
               48                                                       55
 50
 40
  30                                                                                             POOR
  20                                                                                             NOT POOR
  10
   0
            TOTAL
         CHOLESTEROL           HDL
                                             TRIGLICERIDES                                        N = 1403
                                                                      LDL
LIPID PROFILE´S

                         Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
Cardiometabolic Risk Factors
Differences Between High-Income and Low-Incomes Populations
                     Insulin Resistence and Diabetes Mellitus

                                                             34
35
30                   RRR 67%
25                 21                              24
 20
                                7                                                   POOR
 15                                                                                 NOT POOR
 10
     5
     0

         Diabetes Mellitus
                                      Insulin Resistence(Glucosa > 100 / < 126 mg7dl )
                  Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
Prevalence of Hypertension in the Central
American and the Caribbean                           REP DOMINICANA
                                                        .
                                                     COS RICA
                                                          TA
                                                                            PANAMA
                                                                            NICARAGUA
                                                     HONDURAS               EL SALVADOR
                                                     GUATEMALA



         0             10                  20                  30                  40

                                      36%

                             28%
                            25%
% HTA                 20%
                      20%
               10%
                             27%

                      Wyss et al, CLCC, from Central Americareportados por Board, march 2008
                           Wyss, et al. CLACC resultados and Caribbean el grupo coordinado
Prevalencia de dislipidemia en el área
    Prevalence of Dyslipidemia in the Central
             centroamericana
                     American and the Caribbean
                                                                                        200



                            55%                                                         150
                                                                         24%
  26%                                                                                   100
                            60%                  23%                     51%
   45%                                           34%
                                                                                        50

                            65%                                          70%
   48%                                           50%
                                                                                        0
Col est er ol               HDL                   LDL                Tr igl icer idos

                Guatemala          Costa Rica             Rep. Dominicana

                            Wyss et al, CLCC, fromresultados reportados por el grupo coordinador
                              Wyss, et al. CLACC Central America and Caribbean Board, march 2008
Prevalencia de Alteraciones de la Glucosa
   Prevalence of Diabetes in thea la Insulina
       Diabetes - Resistencia Central American
                          and the Caribbean
              0             12,5               25
                                                                  37,5
                                                                                        50


 Diabetes     12%       3% 5%           8%          5%         9%


Prediabetes
                                35%
                                                             4%

  Guatemala       El Salvador         Honduras         Costa Rica          Rep. Dominicana
  Nicaragua

                         Wyss et al, CLCC, from Central America and Caribbean Board, march 2008
                           Wyss, et al. CLACC resultados reportados por el grupo coordinador
Centroamérica American
Prevalence of obesity in the Central
                and the Caribbean

                        18%                  68%


             67%



                                  73%



Guatem ala    El Salvador           Costa Rica            Rep. Dom inicana
               Wyss et al, CLCC, from Central America and Caribbean Board, march 2008
CONCLUSIONS




              National Statistics Institute INE - Guatemala, 2006
CENTRAL AMERICA AND CARIBBEAN
                     In some countries of the Region, out-of-pocket expenditures account for up
                        to 78% of spending on medicines, and this can be catastrophic for low-
                                          income families and populations.


Rich People                       Middle Class                            Poor People




  1. Overweight                1. Overweight / Obesity                1. Obesity
  2. Prehypertension           2. Hypertension I - II                 2. Hypertension II - I
  3. Mild dyslipidemia         3. Mixed Dyslipidemia                  3. Mixed Dyslipidemia
  4. Smoking                   4. Smoking                             4. Diabetes / IR
                               5. IR / Diabetes
1. Money makes the difference in CVD and MACCE

2. The provision of human resources and training materials
   in adequate number if necessary

3. Access to primary prevention for POOR PEOPLE

4. Improved accessibility and availability of medicines

1. The impact of social, demographic, epidemiological and
   technological advances in CVD requires reorienting
   periodically plans of study, undergraduate and
   graduate, in each country to adapt to their training
   needs.
Pan American Health Organization.
“Regional Consultation: Priorities for Cardiovascular Health in the Americas. Key Messages for Policymakers”
                                                                            Washington, D.C.: PAHO, © 2011-
Cost-Effectiveness of Community-Based Strategies for
Blood Pressure Control in a Low-Income Developing
Country: Findings From a Cluster-Randomized, Factorial-
Controlled Trial
 1. Combined Home Health Education (HHE) plus Trained General
    Practitioner (GP)
 2. HHE only
 3. Trained GP only

                               of HHE plus trained GP is
 potentially affordable and more cost-effective for BP
 control than usual care or either strategy alone in some
 communities in Pakistan, and possibly other countries in
 Indochina with similar healthcare infrastructure.

                                        Circulation. 2011;124:1615-1625
Globalization / Urbanization and the Epidemiologic Transition




                                                                                     Pan American Health Organization.
           “Regional Consultation: Priorities for Cardiovascular Health in the Americas. Key Messages for Policymakers”
                                                                                       Washington, D.C.: PAHO, © 2011-
We have a social difference
   in the appearance of
 Cardiovascular Disease ?




    Economic Growth
         Income
      Employment

More Related Content

Viewers also liked

Supporting new pathways in discontinuous learning
Supporting new pathways in discontinuous learningSupporting new pathways in discontinuous learning
Supporting new pathways in discontinuous learning
Gillian Palmer
 
Aneks09
Aneks09Aneks09
Aneks09
JacekKupras
 
Obliterate your Customer Processes
Obliterate your Customer ProcessesObliterate your Customer Processes
Obliterate your Customer Processes
Brad Power
 
Jason Hsu TEDx-workshop-China
Jason Hsu TEDx-workshop-ChinaJason Hsu TEDx-workshop-China
Jason Hsu TEDx-workshop-China
TEDtoChina
 
Computingtransformations Spring2005
Computingtransformations Spring2005Computingtransformations Spring2005
Computingtransformations Spring2005
1Leu
 
Sindromul X Fragil
Sindromul X FragilSindromul X Fragil
Sindromul X Fragil1Leu
 
TEDxNanjing
TEDxNanjingTEDxNanjing
TEDxNanjing
TEDtoChina
 
Slide
SlideSlide
Slide
Panduro
 
Breakdowns and Breakthroughs: Handoffs Between Sales and Marketing
Breakdowns and Breakthroughs: Handoffs Between Sales and MarketingBreakdowns and Breakthroughs: Handoffs Between Sales and Marketing
Breakdowns and Breakthroughs: Handoffs Between Sales and Marketing
Brad Power
 
Group Presentation - Capstone Course Walden University
Group Presentation - Capstone Course Walden UniversityGroup Presentation - Capstone Course Walden University
Group Presentation - Capstone Course Walden University
Melanie Hannasch
 
Pc Ware Norway Consepts And Solutions 2009
Pc Ware Norway   Consepts And Solutions  2009Pc Ware Norway   Consepts And Solutions  2009
Pc Ware Norway Consepts And Solutions 2009
siggen64
 
Facebook Advertising: Big Ideas for Small Business
Facebook Advertising: Big Ideas for Small BusinessFacebook Advertising: Big Ideas for Small Business
Facebook Advertising: Big Ideas for Small Business
Jeff Ebbing
 
Process Innovation Capabilities Diagnostic Tool - Working Draft
Process Innovation Capabilities Diagnostic Tool - Working DraftProcess Innovation Capabilities Diagnostic Tool - Working Draft
Process Innovation Capabilities Diagnostic Tool - Working Draft
Brad Power
 
Corporate Presentation V3
Corporate Presentation V3Corporate Presentation V3
Corporate Presentation V3
TheHolloway
 
Pc Ware Datasenter Løsninger 2009
Pc Ware   Datasenter Løsninger 2009Pc Ware   Datasenter Løsninger 2009
Pc Ware Datasenter Løsninger 2009siggen64
 
Sex Differences In Relationships
Sex Differences In RelationshipsSex Differences In Relationships
Sex Differences In Relationships
1Leu
 
Brawl
BrawlBrawl
Globeatnightpakiet
GlobeatnightpakietGlobeatnightpakiet
Globeatnightpakiet
JacekKupras
 
COST- SEG Presentation
COST- SEG PresentationCOST- SEG Presentation
COST- SEG Presentation
Teresa H
 

Viewers also liked (20)

Supporting new pathways in discontinuous learning
Supporting new pathways in discontinuous learningSupporting new pathways in discontinuous learning
Supporting new pathways in discontinuous learning
 
Aneks09
Aneks09Aneks09
Aneks09
 
Obliterate your Customer Processes
Obliterate your Customer ProcessesObliterate your Customer Processes
Obliterate your Customer Processes
 
Jason Hsu TEDx-workshop-China
Jason Hsu TEDx-workshop-ChinaJason Hsu TEDx-workshop-China
Jason Hsu TEDx-workshop-China
 
Computingtransformations Spring2005
Computingtransformations Spring2005Computingtransformations Spring2005
Computingtransformations Spring2005
 
Sindromul X Fragil
Sindromul X FragilSindromul X Fragil
Sindromul X Fragil
 
TEDxNanjing
TEDxNanjingTEDxNanjing
TEDxNanjing
 
Slide
SlideSlide
Slide
 
Breakdowns and Breakthroughs: Handoffs Between Sales and Marketing
Breakdowns and Breakthroughs: Handoffs Between Sales and MarketingBreakdowns and Breakthroughs: Handoffs Between Sales and Marketing
Breakdowns and Breakthroughs: Handoffs Between Sales and Marketing
 
Group Presentation - Capstone Course Walden University
Group Presentation - Capstone Course Walden UniversityGroup Presentation - Capstone Course Walden University
Group Presentation - Capstone Course Walden University
 
Pc Ware Norway Consepts And Solutions 2009
Pc Ware Norway   Consepts And Solutions  2009Pc Ware Norway   Consepts And Solutions  2009
Pc Ware Norway Consepts And Solutions 2009
 
Facebook Advertising: Big Ideas for Small Business
Facebook Advertising: Big Ideas for Small BusinessFacebook Advertising: Big Ideas for Small Business
Facebook Advertising: Big Ideas for Small Business
 
Process Innovation Capabilities Diagnostic Tool - Working Draft
Process Innovation Capabilities Diagnostic Tool - Working DraftProcess Innovation Capabilities Diagnostic Tool - Working Draft
Process Innovation Capabilities Diagnostic Tool - Working Draft
 
Corporate Presentation V3
Corporate Presentation V3Corporate Presentation V3
Corporate Presentation V3
 
Pc Ware Datasenter Løsninger 2009
Pc Ware   Datasenter Løsninger 2009Pc Ware   Datasenter Løsninger 2009
Pc Ware Datasenter Løsninger 2009
 
Oev Test
Oev TestOev Test
Oev Test
 
Sex Differences In Relationships
Sex Differences In RelationshipsSex Differences In Relationships
Sex Differences In Relationships
 
Brawl
BrawlBrawl
Brawl
 
Globeatnightpakiet
GlobeatnightpakietGlobeatnightpakiet
Globeatnightpakiet
 
COST- SEG Presentation
COST- SEG PresentationCOST- SEG Presentation
COST- SEG Presentation
 

Similar to Factores Socioeconomicos y riesgo cardiovascular

Reducing Cancer Challenge Webinar Slides (12/6/12)
Reducing Cancer Challenge Webinar Slides (12/6/12)Reducing Cancer Challenge Webinar Slides (12/6/12)
Reducing Cancer Challenge Webinar Slides (12/6/12)
health2dev
 
Reducing Cancer Challenge Webinar Deck (12/6/12)
Reducing Cancer Challenge Webinar Deck (12/6/12)Reducing Cancer Challenge Webinar Deck (12/6/12)
Reducing Cancer Challenge Webinar Deck (12/6/12)
health2dev
 
Closing the gap in a generation: Health equity through action on thesocial de...
Closing the gap in a generation: Health equity through action on thesocial de...Closing the gap in a generation: Health equity through action on thesocial de...
Closing the gap in a generation: Health equity through action on thesocial de...
testsample
 
Dr. Klaus Hornetz Presentantion on NCDs 2011
Dr. Klaus Hornetz Presentantion on NCDs 2011Dr. Klaus Hornetz Presentantion on NCDs 2011
Dr. Klaus Hornetz Presentantion on NCDs 2011
gizhsp
 
Good Global Governance for Action on Social Determinants of Health: Lessons f...
Good Global Governance for Action on Social Determinants of Health: Lessons f...Good Global Governance for Action on Social Determinants of Health: Lessons f...
Good Global Governance for Action on Social Determinants of Health: Lessons f...
Renzo Guinto
 
Investing in health of nigerians
Investing in health of nigeriansInvesting in health of nigerians
Investing in health of nigerians
Oladele Situ
 
Investing in health of nigerians
Investing in health of nigeriansInvesting in health of nigerians
Investing in health of nigerians
Oladele Situ
 
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
CityAge
 
Hiv Testing VA Goetz
Hiv Testing VA GoetzHiv Testing VA Goetz
Hiv Testing VA Goetz
HIV_STD_Partners_Meeting
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
Dlgltsbm
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
Dlgltsbm
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
Dlgltsbm
 
Personalized Healthcare and Research
Personalized Healthcare and ResearchPersonalized Healthcare and Research
Personalized Healthcare and Research
Ryan Squire
 
GHIs in Mozambique
GHIs in Mozambique GHIs in Mozambique
GHIs in Mozambique
GlobalHealthObserver
 
Klaus naivasha1 2011 nc ds[1]
Klaus naivasha1 2011 nc ds[1]Klaus naivasha1 2011 nc ds[1]
Klaus naivasha1 2011 nc ds[1]
gizhsp2
 
Mortality
MortalityMortality
Mortality
kdjw
 
2009 Convegno Malattie Rare Tamburlini [23 01]
2009 Convegno Malattie Rare Tamburlini [23 01]2009 Convegno Malattie Rare Tamburlini [23 01]
2009 Convegno Malattie Rare Tamburlini [23 01]
cmid
 
Health in the Philippines
Health in the PhilippinesHealth in the Philippines
Health in the Philippines
Renzo Guinto
 
Human Population Ecology
Human Population EcologyHuman Population Ecology
Human Population Ecology
tcooper66
 
Healthcare Presentation
Healthcare PresentationHealthcare Presentation
Healthcare Presentation
LEAD VIRGINIA
 

Similar to Factores Socioeconomicos y riesgo cardiovascular (20)

Reducing Cancer Challenge Webinar Slides (12/6/12)
Reducing Cancer Challenge Webinar Slides (12/6/12)Reducing Cancer Challenge Webinar Slides (12/6/12)
Reducing Cancer Challenge Webinar Slides (12/6/12)
 
Reducing Cancer Challenge Webinar Deck (12/6/12)
Reducing Cancer Challenge Webinar Deck (12/6/12)Reducing Cancer Challenge Webinar Deck (12/6/12)
Reducing Cancer Challenge Webinar Deck (12/6/12)
 
Closing the gap in a generation: Health equity through action on thesocial de...
Closing the gap in a generation: Health equity through action on thesocial de...Closing the gap in a generation: Health equity through action on thesocial de...
Closing the gap in a generation: Health equity through action on thesocial de...
 
Dr. Klaus Hornetz Presentantion on NCDs 2011
Dr. Klaus Hornetz Presentantion on NCDs 2011Dr. Klaus Hornetz Presentantion on NCDs 2011
Dr. Klaus Hornetz Presentantion on NCDs 2011
 
Good Global Governance for Action on Social Determinants of Health: Lessons f...
Good Global Governance for Action on Social Determinants of Health: Lessons f...Good Global Governance for Action on Social Determinants of Health: Lessons f...
Good Global Governance for Action on Social Determinants of Health: Lessons f...
 
Investing in health of nigerians
Investing in health of nigeriansInvesting in health of nigerians
Investing in health of nigerians
 
Investing in health of nigerians
Investing in health of nigeriansInvesting in health of nigerians
Investing in health of nigerians
 
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
Treatment as Prevention The Key to an AIDS & HIV free Generation or Harnessin...
 
Hiv Testing VA Goetz
Hiv Testing VA GoetzHiv Testing VA Goetz
Hiv Testing VA Goetz
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
 
08worlddatasheet presentation
08worlddatasheet presentation08worlddatasheet presentation
08worlddatasheet presentation
 
Personalized Healthcare and Research
Personalized Healthcare and ResearchPersonalized Healthcare and Research
Personalized Healthcare and Research
 
GHIs in Mozambique
GHIs in Mozambique GHIs in Mozambique
GHIs in Mozambique
 
Klaus naivasha1 2011 nc ds[1]
Klaus naivasha1 2011 nc ds[1]Klaus naivasha1 2011 nc ds[1]
Klaus naivasha1 2011 nc ds[1]
 
Mortality
MortalityMortality
Mortality
 
2009 Convegno Malattie Rare Tamburlini [23 01]
2009 Convegno Malattie Rare Tamburlini [23 01]2009 Convegno Malattie Rare Tamburlini [23 01]
2009 Convegno Malattie Rare Tamburlini [23 01]
 
Health in the Philippines
Health in the PhilippinesHealth in the Philippines
Health in the Philippines
 
Human Population Ecology
Human Population EcologyHuman Population Ecology
Human Population Ecology
 
Healthcare Presentation
Healthcare PresentationHealthcare Presentation
Healthcare Presentation
 

More from Edgar Hernández

JNC 8: ¿Qué hay de nuevo?
JNC 8: ¿Qué hay de nuevo?JNC 8: ¿Qué hay de nuevo?
JNC 8: ¿Qué hay de nuevo?
Edgar Hernández
 
Panorama Actual de la Enfermedad de Chagas
Panorama Actual de la Enfermedad de ChagasPanorama Actual de la Enfermedad de Chagas
Panorama Actual de la Enfermedad de Chagas
Edgar Hernández
 
Rehabilitación Cardíaca en Insuficiencia Cardíaca
Rehabilitación Cardíaca en Insuficiencia CardíacaRehabilitación Cardíaca en Insuficiencia Cardíaca
Rehabilitación Cardíaca en Insuficiencia Cardíaca
Edgar Hernández
 
Crisis hipertensivas
Crisis hipertensivasCrisis hipertensivas
Crisis hipertensivas
Edgar Hernández
 
Esc 2011
Esc 2011Esc 2011
DES
DESDES
Marcapasos
MarcapasosMarcapasos
Marcapasos
Edgar Hernández
 
Terapia inapropiada en dai
Terapia inapropiada en daiTerapia inapropiada en dai
Terapia inapropiada en dai
Edgar Hernández
 
Resincronización Cardíaca
Resincronización CardíacaResincronización Cardíaca
Resincronización Cardíaca
Edgar Hernández
 
Acute Heart Failure
Acute Heart FailureAcute Heart Failure
Acute Heart Failure
Edgar Hernández
 
Outpatient Management of Heart Failure
Outpatient Management of Heart FailureOutpatient Management of Heart Failure
Outpatient Management of Heart Failure
Edgar Hernández
 
Biomarkers in Heart Failure
Biomarkers in Heart FailureBiomarkers in Heart Failure
Biomarkers in Heart Failure
Edgar Hernández
 
Supraventriculares
SupraventricularesSupraventriculares
Supraventriculares
Edgar Hernández
 
Cambios en acls guias 2010
Cambios en acls guias 2010Cambios en acls guias 2010
Cambios en acls guias 2010
Edgar Hernández
 
Reanimación Cardiopulmonar 2010
Reanimación Cardiopulmonar 2010Reanimación Cardiopulmonar 2010
Reanimación Cardiopulmonar 2010
Edgar Hernández
 
Catéter de Swan-Ganz
Catéter de Swan-GanzCatéter de Swan-Ganz
Catéter de Swan-Ganz
Edgar Hernández
 
Embolia Pulmonar
Embolia PulmonarEmbolia Pulmonar
Embolia Pulmonar
Edgar Hernández
 
Drogas antihipertensivas
Drogas antihipertensivasDrogas antihipertensivas
Drogas antihipertensivas
Edgar Hernández
 
Síndromes Coronarios Agudos
Síndromes Coronarios AgudosSíndromes Coronarios Agudos
Síndromes Coronarios Agudos
Edgar Hernández
 
Enfermedad Coronaria Estable
Enfermedad Coronaria EstableEnfermedad Coronaria Estable
Enfermedad Coronaria Estable
Edgar Hernández
 

More from Edgar Hernández (20)

JNC 8: ¿Qué hay de nuevo?
JNC 8: ¿Qué hay de nuevo?JNC 8: ¿Qué hay de nuevo?
JNC 8: ¿Qué hay de nuevo?
 
Panorama Actual de la Enfermedad de Chagas
Panorama Actual de la Enfermedad de ChagasPanorama Actual de la Enfermedad de Chagas
Panorama Actual de la Enfermedad de Chagas
 
Rehabilitación Cardíaca en Insuficiencia Cardíaca
Rehabilitación Cardíaca en Insuficiencia CardíacaRehabilitación Cardíaca en Insuficiencia Cardíaca
Rehabilitación Cardíaca en Insuficiencia Cardíaca
 
Crisis hipertensivas
Crisis hipertensivasCrisis hipertensivas
Crisis hipertensivas
 
Esc 2011
Esc 2011Esc 2011
Esc 2011
 
DES
DESDES
DES
 
Marcapasos
MarcapasosMarcapasos
Marcapasos
 
Terapia inapropiada en dai
Terapia inapropiada en daiTerapia inapropiada en dai
Terapia inapropiada en dai
 
Resincronización Cardíaca
Resincronización CardíacaResincronización Cardíaca
Resincronización Cardíaca
 
Acute Heart Failure
Acute Heart FailureAcute Heart Failure
Acute Heart Failure
 
Outpatient Management of Heart Failure
Outpatient Management of Heart FailureOutpatient Management of Heart Failure
Outpatient Management of Heart Failure
 
Biomarkers in Heart Failure
Biomarkers in Heart FailureBiomarkers in Heart Failure
Biomarkers in Heart Failure
 
Supraventriculares
SupraventricularesSupraventriculares
Supraventriculares
 
Cambios en acls guias 2010
Cambios en acls guias 2010Cambios en acls guias 2010
Cambios en acls guias 2010
 
Reanimación Cardiopulmonar 2010
Reanimación Cardiopulmonar 2010Reanimación Cardiopulmonar 2010
Reanimación Cardiopulmonar 2010
 
Catéter de Swan-Ganz
Catéter de Swan-GanzCatéter de Swan-Ganz
Catéter de Swan-Ganz
 
Embolia Pulmonar
Embolia PulmonarEmbolia Pulmonar
Embolia Pulmonar
 
Drogas antihipertensivas
Drogas antihipertensivasDrogas antihipertensivas
Drogas antihipertensivas
 
Síndromes Coronarios Agudos
Síndromes Coronarios AgudosSíndromes Coronarios Agudos
Síndromes Coronarios Agudos
 
Enfermedad Coronaria Estable
Enfermedad Coronaria EstableEnfermedad Coronaria Estable
Enfermedad Coronaria Estable
 

Recently uploaded

Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 

Recently uploaded (20)

Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 

Factores Socioeconomicos y riesgo cardiovascular

  • 1. DISCLOSURE Advisory Board Novartis Research Aztra Zeneca Sanofi Aventis Schering Plough Asofarma Pfizer Merck Serono Merck Sharp Dohme Bayer Abbott Servier Roche Menarini Takeda Ferrer
  • 2. Globalization / Urbanization and the Epidemiologic Transition Economic Growth, Income, Employment and Cardiovascular Disease Dr. Fernando Stuardo Wyss Quintana Md, Phd, GCSM, ESHM, ESCM Vice-president of Interamerican Society of Cardiology Guatemala City, Guatemala, C.A. fernandowyss@gmail.com
  • 3. Our final Conclusion be that from the point of view of Cardiovascular Disease powerfuls, arrogants and impotents
  • 4. The National Survey of Living Conditions ENCOVI 2006 Vital Basic Basket and Minimum Wage VITAL BASIC BASKET FOOD AGRICULTURE WAGE NOT AGRICULTURE WAGE Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
  • 5. The National Survey of Living Conditions ENCOVI 2006 Vital Basic Basket and Minimum Wage In accordance with Government Agreement No. 388-2010 published in the Journal of Central America, December 30, 2010, establishes the new minimum wage that governed from January 1, 2011. - Agriculture / not Agriculture Q. 2,187.54 per month $ 276.90 - Export and manufacture Q. 2,058.27 per month $ 260.24 - Cardiologist in GH Q. 4,000.00 per month $ 506.32 Wyss; Source: Based on data: Guatemala 2011 government salary
  • 6. The National Survey of Living Conditions ENCOVI 2006 Guatemala: Poverty nationwide distribution of poverty by ethnic identity National Survey of Living Conditions 2006 ENCOVI absolute and relative numbers 80% 75 70 64 60 51 49 50 48 All Population 40 36 36 29 Indigenous 30 27 25 Non-Indigenous 20 15 10 8 0 All Poor Extremely Poor Poor Not Poor N = 12,987,829 Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
  • 7. The National Survey of Living Conditions ENCOVI 2006 Guatemala: Poverty Incidence by Region All Poor´ 51% Extremely poor 15% Poor 36% Not Poor 49% Wyss; Source: Based on data from the National Survey of Living Conditions ENCOVI 2006.
  • 8. The National Survey of Living Conditions ENCOVI 2006 Incidence of Poverty in each Department Poor Not Poor Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
  • 9. The National Survey of Living Conditions ENCOVI 2006 Guatemala: Social Spending on Education, Health and Housing % Of GDP (Gross Domestic Product), 2001 -2007. Education Health Housing 1.75 74 % Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
  • 10. The National Survey of Living Conditions ENCOVI 2006 Guatemala: Social Spending on Health % Of GDP (Gross Domestic Product), 2001 -2007. % GDP 2001 - 2007 Guatemala El Salvador Honduras Nicaragua Costa Rica Panama Wyss; Source: Based on data from the National Survey of Living Conditions 2006 ENCOVI
  • 11. Cardiovascular Risk Assessment in Guatemala • General population • Bedroom City´s • Chronically ill population • High-income population
  • 12. Data in Pediatric Populations OBESITY IN ELEMENTARY SCHOOL EDUCATION, UNIVERSITY OF SAN CARLOS DE GUATEMALA 67% Dr. Luis Moya MD, PhD; Verbal Information
  • 13. Cardiometabolic Risk Factors Guatemalan Heart League 7000 5250 3500 1750 0 2001 2002 2003 2004 2005 2006 2007 Hypertension N = 111,201 Diabetes Mellitus Dyslipidemia Dr. Wyss, Data Base; Guatemalan Heart League
  • 14. Cardiometabolic Risk Factors Guatemalan Heart League % 35 34 35 30 25 25 20 2001 15 2007 10 8 8 2008 5 4 6 6 0 3 Hypertension Diabetes Mellitus Dyslipidemia N = 111,201 Dr. Wyss, Data Base; Guatemalan Heart League
  • 15. Ciudad Dormitorio Commuter Town Study Sx. Metabólico Ciudad Villa Nueva The Villa Nueva Study, Cardiovascular CDC Porcentaje de Factores de Riesgo OPS, OMS 0 15 30 45 60 55% 29% FRCV 23% 40% 54% Abnormal glucouse Gl ucemia anor mal Hiper t ension Hypertension Overweigth Sobr epeso Obesity Obesidad Cint ur a Circunference Abdominal OPS, OMS, Villa Nueva Study Paper
  • 16. Prevalence de Síndrome Syndrome Prevalencia of Metabolic Metabólico Clínica de Hipertensión Hypertension Unit, St. Jhon of God General Hospital Hospital General San Juan de Dios 1100 100% 90% 825 70% 65% 55% 550 48% 45% 24% 275 21% 0 Hypertension Hipertensión HDL TG Colesterol LDL Glucosa > 100 DM2 Prediabetes Obesidad Obesity N = 1005 8 com ponentes aislados Dr. Wyss, in print,Dr. Fernando Wyss, unidad and St. Jhon of God General Hospital Fuente: database Cardioclinik Research Unit de cardiología HGSJDD
  • 17. Global Cardiovascular Risk Assessment in an apparently healthy population EVRICARDS • 398 patients • Routine Cardiovascular Screening Perfil PROFILE LIPID Lípidos • High income 300 • Lifestyle modification 58% 225 51% • Fitness cardiovascular activity 44% • Play Golf 32% 29% 150 • Balanced diet 19% 75 • They drink wine 177 p 128 p 76 p 116 p 205 p 231 p 0 LIPIDOS Colesterol HDL - M HDL - F LDL > 130 LDL > 100 Trigliceridos Clasificación PRESURE BLOOD Presión Arterial P. Sistólica P. Diastólica Fernando Wyss; in press, 2 0 1 0 0 22,5 45 67,5 90 Normal 40% 38% Pre- hipertensión 40% Estadio 1 42% 10% 11% Estadio 2 10% 9% Fernando Wyss; in press, 2010
  • 18. Economic Growth, Income, Employment and Cardiovascular Disease ?? We have a social difference in the appearance of cardiovascular disease ?
  • 19. Gross Domestic Product and Health Expenditure Associated With Incidence, 30-Day Fatality, and Age at Stroke Onset, A Systematic Review Luciano A. Sposato, MD, MBA; Gustavo Saposnik, MD, MSc, FAHA This study demonstrated an association between low GDP of a country: 1. A 32% increase stroke risk 2. An increase in the rate of death at 30 days post-stroke by 43% 3. An excess of 43% in intracerebral hemorrhage 4. An increase of almost double the incidence of stroke in young individuals. Stroke. 2012; 43 /doi: 10.1161/​STROKEAHA.111.632158
  • 20. Gross Domestic Product and Health Expenditure Associated With Incidence, 30-Day Fatality, and Age at Stroke Onset, A Systematic Review Luciano A. Sposato, MD, MBA; Gustavo Saposnik, MD, MSc, FAHA Also, a low total health expenditure was correlated with a proportional increase in the rate of death at 30 days and: 1. A 26% increase stroke risk 2. An increase of 45% death rate at 30 days post-stroke 3. An excess of 32% in intracerebral hemorrhage 4. A 36% increase in the incidence of stroke in young individuals. Stroke. 2012; 43 /doi: 10.1161/​STROKEAHA.111.632158
  • 21. Intervention Model High Income and compare the Relative Risk Reduction of Low-Income
  • 22. Cardiometabolic Risk Factors Differences Between High-Income and Low-Incomes Populations Obesity 100 RRR 4% 28 RRR 11% 26 29 29 90 80 70 161 169 151 157 60 BMI 50 HEIGHT cm 40 WEIGTH kg 30 20 74 80 65 66 10 0 N = 1403 POOR male NOT POOR POOR female NOT POOR male female Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
  • 23. Cardiometabolic Risk Factors Differences Between High-Income and Low-Incomes Populations Abdominal Circunference 96 90 NOT POOR MALE RRR 5% FEMALE 94 94 POOR N = 1403 0 20 40 60 80 100 Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
  • 24. Cardiometabolic Risk Factors Differences Between High-Income and Low-Incomes Populations RRR 9% 27% 18% 32% 70 % 65 70 58 60 44 48 51 48 55 50 40 30 POOR 20 NOT POOR 10 0 TOTAL CHOLESTEROL HDL TRIGLICERIDES N = 1403 LDL LIPID PROFILE´S Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
  • 25. Cardiometabolic Risk Factors Differences Between High-Income and Low-Incomes Populations Insulin Resistence and Diabetes Mellitus 34 35 30 RRR 67% 25 21 24 20 7 POOR 15 NOT POOR 10 5 0 Diabetes Mellitus Insulin Resistence(Glucosa > 100 / < 126 mg7dl ) Dr. Wyss, in print, database Cardioclinik Research Unit and St. Jhon of God General Hospital
  • 26. Prevalence of Hypertension in the Central American and the Caribbean REP DOMINICANA . COS RICA TA PANAMA NICARAGUA HONDURAS EL SALVADOR GUATEMALA 0 10 20 30 40 36% 28% 25% % HTA 20% 20% 10% 27% Wyss et al, CLCC, from Central Americareportados por Board, march 2008 Wyss, et al. CLACC resultados and Caribbean el grupo coordinado
  • 27. Prevalencia de dislipidemia en el área Prevalence of Dyslipidemia in the Central centroamericana American and the Caribbean 200 55% 150 24% 26% 100 60% 23% 51% 45% 34% 50 65% 70% 48% 50% 0 Col est er ol HDL LDL Tr igl icer idos Guatemala Costa Rica Rep. Dominicana Wyss et al, CLCC, fromresultados reportados por el grupo coordinador Wyss, et al. CLACC Central America and Caribbean Board, march 2008
  • 28. Prevalencia de Alteraciones de la Glucosa Prevalence of Diabetes in thea la Insulina Diabetes - Resistencia Central American and the Caribbean 0 12,5 25 37,5 50 Diabetes 12% 3% 5% 8% 5% 9% Prediabetes 35% 4% Guatemala El Salvador Honduras Costa Rica Rep. Dominicana Nicaragua Wyss et al, CLCC, from Central America and Caribbean Board, march 2008 Wyss, et al. CLACC resultados reportados por el grupo coordinador
  • 29. Centroamérica American Prevalence of obesity in the Central and the Caribbean 18% 68% 67% 73% Guatem ala El Salvador Costa Rica Rep. Dom inicana Wyss et al, CLCC, from Central America and Caribbean Board, march 2008
  • 30. CONCLUSIONS National Statistics Institute INE - Guatemala, 2006
  • 31. CENTRAL AMERICA AND CARIBBEAN In some countries of the Region, out-of-pocket expenditures account for up to 78% of spending on medicines, and this can be catastrophic for low- income families and populations. Rich People Middle Class Poor People 1. Overweight 1. Overweight / Obesity 1. Obesity 2. Prehypertension 2. Hypertension I - II 2. Hypertension II - I 3. Mild dyslipidemia 3. Mixed Dyslipidemia 3. Mixed Dyslipidemia 4. Smoking 4. Smoking 4. Diabetes / IR 5. IR / Diabetes
  • 32. 1. Money makes the difference in CVD and MACCE 2. The provision of human resources and training materials in adequate number if necessary 3. Access to primary prevention for POOR PEOPLE 4. Improved accessibility and availability of medicines 1. The impact of social, demographic, epidemiological and technological advances in CVD requires reorienting periodically plans of study, undergraduate and graduate, in each country to adapt to their training needs.
  • 33. Pan American Health Organization. “Regional Consultation: Priorities for Cardiovascular Health in the Americas. Key Messages for Policymakers” Washington, D.C.: PAHO, © 2011-
  • 34. Cost-Effectiveness of Community-Based Strategies for Blood Pressure Control in a Low-Income Developing Country: Findings From a Cluster-Randomized, Factorial- Controlled Trial 1. Combined Home Health Education (HHE) plus Trained General Practitioner (GP) 2. HHE only 3. Trained GP only of HHE plus trained GP is potentially affordable and more cost-effective for BP control than usual care or either strategy alone in some communities in Pakistan, and possibly other countries in Indochina with similar healthcare infrastructure. Circulation. 2011;124:1615-1625
  • 35. Globalization / Urbanization and the Epidemiologic Transition Pan American Health Organization. “Regional Consultation: Priorities for Cardiovascular Health in the Americas. Key Messages for Policymakers” Washington, D.C.: PAHO, © 2011-
  • 36. We have a social difference in the appearance of Cardiovascular Disease ? Economic Growth Income Employment